marine link image
Register now for the Port of the Future Conference • 2 Days, 50 Ports • Houston/Galveston area, TX • April 12–14, 2027

LNG Carrier CESI Tianjin Delivered for SINOPEC LNG Project

September 27, 2017

 Mitsui O.S.K. Lines (MOL)  announced that the LNG carrier CESI Tianjin, which was ordered by the joint venture of MOL, China COSCO Shipping Corporation Limited (China COSCO Shipping) and China Petroleum & Chemical Corporation (SINOPEC), was delivered at Hudong-Zhonghua Shipbuilding (Group) Co., Ltd. (Hudong) on September 26.

 
The CESI Tianjin is the fourth vessel to serve the LNG transport project for SINOPEC announced in April 2013, and will sail under a long-term charter contract to transport LNG that SINOPEC will purchase from the Australia Pacific LNG Project.
 
A total of six newbuilding LNG carriers are being built at Hudong. The first vessel, the CESI Gladstone was delivered in October 2016, the second, the CESI Qingdao in January 2017, and the third, the CESI Beihai, in June 2017. The remaining two are slated to be delivered by 2018.
 
MOL takes a proactive stance in acquiring new projects while newly leveraging this experience in international joint projects, and strives to offer value-added transport services to customers all over the world.
 

Logistics News

AAPA Presents 2026 Lighthouse Award to Winners for Port Industry Excellence

AAPA Presents 2026 Lighthouse Award to Winners for Port Industry Excellence

Hapag-Lloyd: Israel Should Review Improved ZIM Offer

Hapag-Lloyd: Israel Should Review Improved ZIM Offer

SSE Picks Montrose Port for 1.4GW Scottish Offshore Wind Farm Ops Base

SSE Picks Montrose Port for 1.4GW Scottish Offshore Wind Farm Ops Base

GTT Marine, Normec Verifavia Announce Emissions Compliance Partnership

GTT Marine, Normec Verifavia Announce Emissions Compliance Partnership

Subscribe for Maritime Logistics Professional E‑News

Wall Street Journal, September 23,
Turkish Airlines will purchase up to 150 Boeing 737 MAX jets
Denmark's central banks expects a 4% growth in GDP by 2026, driven by the pharmaceutical industry